✉news TechnologyTechnology first seen 11 h ago, last 11 h ago, peak #29
Engineering Better Agonistic Antibodies for Cancer Immunotherapy
New coverage from Technology Networks examines efforts to design improved agonistic antibodies, drugs that activate immune-cell receptors to help the body attack tumours. The piece outlines how engineering strategies aim to enhance their potency and safety for cancer immunotherapy, a fast-growing field where several agonistic antibody candidates have struggled to show clinical benefit so far.
Why now: Ongoing interest in improving cancer immunotherapy as researchers seek safer, more effective ways to activate anti-tumour immune responses.
Technology Networksagonistic antibodiescancer immunotherapy
Evidence
- Engineering Better Agonistic Antibodies for Cancer Immunotherapy · Technology Networks
API: https://socialmediatrends-api.osmike.com/v1/trends/470576